#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Salivary gland cancer Squamous cell carcinoma of the hypopharynx B-cell type acute leukaemia Haemophilia A with anti factor VIII Chronic cutaneous lupus erythematosus HER2 gene amplification Cutaneous T-cell lymphoma refractory Hypersensitivity pneumonitis Noonan syndrome Ewing's sarcoma recurrent Osteosarcoma metastatic Non-small cell lung cancer recurrent Cardiomyopathy Peritoneal mesothelioma malignant Leukaemia More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Trials in Disease Carcinoid syndrome – Treatment Gaucher’s disease type III – Diagnostics Pleomorphic leiomyosarcoma – Basic Information Bronchiolitis obliterans syndrome – Treatment Glycogen storage disease type II – Trials in Disease Von Willebrand’s disease – Diagnostics Gaucher’s disease type I – Diagnostics Haemophilia SAPHO syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Digoxin Glucose Vgl101 Sar441566 Latozinemab RO7795081 Masupirdine Collagenase Sildenafil [68GA]GA-NOTA-AE105 Taminadenant Leflunomide Digitoxin Belatacept Rusfertide Vildagliptin Sodium Laurilsulfate Bifikafusp Alfa Messenger Rna Encoding Cas9 IADADEMSTAT More therapies…

    Learn about Your Condition

    Laryngeal cancer stage III Malignant fibrous histiocytoma Prader-Willi syndrome Burning mouth syndrome Traumatic pain Genital infection female Intestinal obstruction Ehlers-Danlos syndrome Anal cancer recurrent Fibromyalgia Methylmalonic acidaemia Dermatitis Leiomyosarcoma recurrent Alopecia areata Cushing's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Safety and Effectiveness of ATTR-01 for Adults with Certain Types of Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • ATTR-01
    Spain

  • Study on the Effectiveness and Safety of Human Normal Immunoglobulin (IV) for Adults with Chronic Immune Thrombocytopenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thrombocytopenia
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    Czechia Germany Italy Romania Spain

  • Study on Botulinum Toxin A for Tinnitus in Patients with Bruxism or Jaw Muscle Pain

    Recruiting

    3 1 1
    Investigated Diseases:
    • Tinnitus
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Norway

  • Study of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Sodium Chloride
    Belgium Italy Spain

  • Study of hydrocortisone and fludrocortisone in patients with intermediate/high-risk scheduled cardiac surgery to prevent complications

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cellulose, Microcrystalline
    • Fludrocortisone
    • Hydrocortisone
    France

  • Study on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Belgium Czechia Denmark Finland France Germany +5
Previous Page
1 … 219 220 221 222 223 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!